Stock listing
TSXV:VXL Vaxil Bio Ltd. Stock
Home listing (TSXV) of Vaxil Bio Ltd.
Follow Vaxil Bio Ltd. into a list and get an email when it puts out news.
Share price · TSXV:VXL
$0.115 CAD 0.000 (0.0%)
Close on Nov 19, 2026
- Day range
- $0.115 – $0.115 CADNov 19, 2026
- Market cap
- $458,162 CADAt the close on Nov 19, 2026 · price × 3.98M shares outstanding
- 52-week range
- $0.100 – $0.290 CADLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- $210 CADMedian day 0 shares · 43 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:VXL · Home | $0.115 CAD | 0.000 (0.0%) | — | $0.115 | $0.115 | $0.115 | $0.115 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · TSXV:VXL · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.115 | 0.000 | 0.0% | $0.115 | $0.115 | $0.115 | 0 | |
| $0.115 | 0.000 | 0.0% | $0.115 | $0.115 | $0.115 | 0 | |
| $0.115 | 0.000 | 0.0% | $0.115 | $0.115 | $0.115 | 0 | |
| $0.115 | +0.005 | +4.5% | $0.115 | $0.115 | $0.115 | 4,500 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 1,522 | |
| $0.110 | 0.000 | 0.0% | $0.140 | $0.140 | $0.110 | 3,000 | |
| $0.110 | +0.010 | +10.0% | $0.110 | $0.110 | $0.110 | 1,121 | |
| $0.100 | 0.000 | 0.0% | $0.100 | $0.100 | $0.100 | 0 | |
| $0.100 | 0.000 | 0.0% | $0.100 | $0.100 | $0.100 | 0 | |
| $0.100 | 0.000 | 0.0% | $0.100 | $0.100 | $0.100 | 0 | |
| $0.100 | 0.000 | 0.0% | $0.100 | $0.100 | $0.100 | 0 | |
| $0.100 | -0.030 | -23.1% | $0.130 | $0.130 | $0.100 | 14,888 | |
| $0.130 | 0.000 | 0.0% | $0.130 | $0.130 | $0.130 | 0 | |
| $0.130 | 0.000 | 0.0% | $0.130 | $0.130 | $0.130 | 500 | |
| $0.130 | 0.000 | 0.0% | $0.130 | $0.130 | $0.130 | 1,000 | |
| $0.130 | -0.015 | -10.3% | $0.140 | $0.140 | $0.130 | 16,000 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 800 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 3,000 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 500 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 3,000 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 500 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 500 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | -0.005 | -3.3% | $0.150 | $0.150 | $0.145 | 3,000 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 504 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 500 | |
| $0.150 | -0.010 | -6.3% | $0.150 | $0.150 | $0.150 | 3,500 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | -0.010 | -5.9% | $0.160 | $0.160 | $0.160 | 20,610 | |
| $0.170 | -0.005 | -2.9% | $0.170 | $0.170 | $0.170 | 2,000 | |
| $0.175 | 0.000 | 0.0% | $0.175 | $0.175 | $0.175 | 0 | |
| $0.175 | 0.000 | 0.0% | $0.175 | $0.175 | $0.175 | 0 | |
| $0.175 | 0.000 | 0.0% | $0.175 | $0.175 | $0.175 | 0 | |
| $0.175 | +0.015 | +9.4% | $0.180 | $0.180 | $0.175 | 12,110 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 4,040 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 |
Splits
3 splits since 2012 · TSXV:VXL · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-50 | Consolidation | |
| 1-for-7 | Consolidation | |
| 1-for-2 | Consolidation |
- Ticker
- TSXV:VXL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TSXV
- Currency
- CAD
What changed lately
Latest news release · Dec 4, 2025
Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors
Latest news
Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors
Dec 4, 2025
Closed $0.14 (0.0%) on Dec 4, 2025
Vaxil Announces Update on Non-Brokered Private Placement
Nov 24, 2025
Closed $0.15 (0.0%) on Nov 24, 2025
Vaxil Bio Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 2 in the last 12 months · 25 in all · newest Dec 4, 2025 · oldest 2005
- Decks
- 2 decks · latest January 2021
Where Vaxil Bio Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:VXL · Home listing · This page | TSXV | Canada | CAD |
| OTC:VXLLF | OTC | United States | USD |
| Cboe Canada:VXL | Cboe Canada | Canada | CAD |
Valuation
Price/book 0.4× against a median of 0.1×: the highest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 19, 2026
- Enterprise value
- −$5,838 CAD
- P/E
- 1.2×
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 0.4×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P/TSX Composite
- -0.16
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Vaxil Bio Ltd. · TSXV:VXL | US$319,477 | −US$4,071 | 1.2× | n/a | n/a | 0.4× | n/a | 0.0× | -0.16 |
| Lakewood-Amedex Biotherapeutics Inc. · NASDAQ:LABT | US$580,337 | −US$2.74M | n/a | n/a | n/a | 0.2× | n/a | 0.0× | 0.46 |
| Mushrooms, Inc. · OTC:MSRM | US$539,339 | US$564,177 | n/a | n/a | n/a | n/a | n/a | n/a | 1.24 |
| Jaguar Health, Inc. · NASDAQ:JAGX | US$527,406 | −US$1.48M | n/a | −0.1× | n/a | 0.0× | −181.8% | 0.2× | 3.75 |
| Altamira Therapeutics Ltd. · OTC:CYTOF | US$404,655 | US$400,900 | n/a | n/a | n/a | 0.1× | n/a | 0.0× | 0.64 |
| NKGen Biotech Inc. · OTC:NKGN | US$391,807 | US$38.58M | n/a | n/a | n/a | n/a | n/a | n/a | 0.88 |
| Chimeric Therapeutics Limited · ASX:CHM | US$292,816 | −US$220,193 | n/a | −0.1× | n/a | 0.2× | −262.8% | 2.5× | n/a |
| CERo Therapeutics Holdings, Inc. · OTC:CERO | US$265,035 | −US$190,890 | n/a | n/a | n/a | n/a | n/a | n/a | 1.47 |
| CDT Equity Inc. · NASDAQ:CDT | US$234,109 | −US$1.49M | n/a | n/a | n/a | 0.0× | n/a | 0.0× | 1.14 |
| GlucoTrack, Inc. · NASDAQ:GCTK | US$217,049 | −US$887,951 | n/a | n/a | n/a | n/a | n/a | n/a | 1.73 |
| Regen BioPharma, Inc. · OTC:RGBP | US$167,528 | US$167,289 | n/a | 0.7× | n/a | n/a | −501.4% | n/a | 1.20 |
| Median of the others | US$342,312 | −US$205,542 | −0.1× | 0.1× | −262.8% | 0.0× | 1.20 |
Team and board
| Officer | Role |
|---|---|
| Gadi Levin | CEO |
Events
- Next results
- Nov 26, 2026 (expected)
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2021) | Investor deck | 15 slides | January 2021 |
| Investor Presentation (October 2020) | Investor deck | 15 slides | October 2020 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of units Closed: C$140,000 raised · C$0.1125 a unit · 1 warrant at C$0.15 for 60 months · free to trade Apr 3, 2026 Use of proceeds: To continue exploring strategic options beyond the health care sector to maximize shareholder value | Dec 4, 2025 | US$100,344 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in CAD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 2.00K | 25.0K | 57.0K | 100.0K | 56.0K | 47.0K | 22.0K | |||
| Gross profit | -2.00K | -25.0K | -57.0K | -100.0K | -56.0K | -47.0K | -22.0K | |||
| Research and development | 12.0K | 114 | 343.0K | 539.0K | 619.0K | 750.0K | 575.0K | 838.0K | 585.0K | |
| Selling, general and administrative | 179.0K | 148.0K | 120 | 239.0K | 428.0K | 724.0K | 383.0K | 466.0K | 965.0K | 3.90M |
| Operating income | -179.0K | -148.0K | -254 | -584.0K | -986.0K | -1.35M | -1.14M | -1.04M | -1.80M | -4.55M |
| Depreciation and amortization | 0 | 2.00K | 25.0K | 57.0K | 100.0K | 56.0K | 47.0K | 22.0K | ||
| EBITDA | -254 | -582.0K | -961.0K | -1.29M | -1.04M | -985.0K | -1.76M | -4.53M | ||
| Interest expense | 4.00K | 11.0K | 11.0K | 0 | 5.00K | 10.0K | ||||
| Income before tax | 521.0K | -130.0K | -254 | -584.0K | -986.0K | -1.36M | -1.15M | -1.05M | -1.80M | -4.54M |
| Income tax | 11.0K | 11.0K | 6.00K | -5.00K | 100.0K | |||||
| Net income | 522.0K | -178.0K | -254 | -584.0K | -986.0K | -1.37M | -1.17M | -1.05M | -1.80M | -4.54M |
| Earnings per share, basic | 0.13 | -0.06 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.04 | -0.12 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 671.0K | 448.0K | 938.0K | 1.51M | 2.24M | 1.51M | 83.0K | 753.0K | 169.0K | 1.02M |
| Receivables | 19.0K | 20.0K | 35.0K | 33.0K | 11.0K | 57.0K | 13.0K | 26.0K | ||
| Inventory | 19.0K | |||||||||
| Current assets | 685.0K | 733.0K | 976.0K | 1.54M | 2.28M | 1.63M | 110.0K | 828.0K | 192.0K | 1.05M |
| Property, plant and equipment | 2.00K | 27.0K | 95.0K | 62.0K | 118.0K | 165.0K | ||||
| Total assets | 1.37M | 733.0K | 976.0K | 1.54M | 2.29M | 1.66M | 205.0K | 890.0K | 310.0K | 1.22M |
| Accounts payable | 85 | 394 | 559 | 588.0K | 618.0K | 335.0K | 438.0K | 370.0K | ||
| Current liabilities | 5.00K | 17.0K | 85.0K | 405.0K | 585.0K | 857.0K | 777.0K | 455.0K | 748.0K | 477.0K |
| Total debt | 9.00K | 17.0K | 5.00K | 78.0K | 17.0K | |||||
| Total liabilities | 5.00K | 17.0K | 85.0K | 405.0K | 585.0K | 857.0K | 788.0K | 455.0K | 797.0K | 561.0K |
| Shareholders' equity | 1.36M | 716.0K | 891.0K | 1.14M | 1.70M | 804.0K | -583.0K | 435.0K | -487.0K | 656.0K |
| Shares outstanding | 3.98M | 2.74M | 137.0M | 137.0M | 136.1M | 101.7M | 88.9M | 85.1M | 50.4M | 39.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -158.0K | -188.0K | -561.0K | -734.0K | -1.08M | -1.10M | -596.0K | -943.0K | -1.00M | -1.50M |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -164.0K |
| Free cash flow | -158.0K | -188.0K | -561.0K | -734.0K | -1.08M | -1.10M | -596.0K | -943.0K | -1.00M | -1.33M |
| Cash from investing | 165.0K | |||||||||
| Cash from financing | 127.0K | 0 | 35.0K | 1.81M | 2.56M | -68.0K | 1.52M | 115.0K | 2.33M | |
| Share buybacks | 150.0K | 2.33M | ||||||||
| Change in cash | 223.0K | -490.0K | -572.0K | -731.0K | 731.0K | 1.43M | -670.0K | 584.0K | -854.0K | 1.01M |
Cap table
Built by 6ix from Vaxil Bio Ltd.’s releases · as of Dec 4, 2025
- Common shares
- 3,984,020
- Fully diluted
- 5,228,461
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 3,984,020 | |
| Warrants | 1,244,441 | Dec 4, 2025 |
Warrants and options
| Lot |
|---|
| Warrants · C$0.15 · expire about Dec 2030 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 3,984,020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gadi Levin | CEO · Since at least Dec 4, 2025 |
Log in to ask 6ix AI your own questions about Vaxil Bio Ltd.